Featured Articles

For investors, the journey from capital deployment to exit often feels uncertain and full of obstacles including

Recent Articles

For investors, the journey from capital deployment to exit often feels uncertain and full of obstacles including

April 9, 2025

Tariff uncertainty is pausing deals, pushing investors to rethink value, resilience, and the new normal in global private equity.

April 7, 2025

US PE market enters 2025 with cautious optimism. Deal volume rises to 1,225, driven by healthcare buyouts. Exit activity remains robust despite economic risks

April 4, 2025

Q4 2024 Healthcare IT PE Update: Steady deal volume amid economic challenges. Major buyouts include R1 RCM ($7.9B) and AdvancedMD ($1.13B)

April 3, 2025

Navigating tariff changes? Enventure offers strategic solutions for family businesses in the US & India. Learn how private equity can turn turbulence into opportunity through supply chain reinvention, margin defense, and capital for change.

March 31, 2025

Q4 2024 ETI Report: High-value investments dominate as AI & ML lead, climate tech surges, and health tech rebounds. Discover emerging trends and insights

March 28, 2025

Healthtech VC trends in Q4 2024 show resilience amid challenges. Discover investment insights, major deals, and how Enventure supports strategic decisions.

March 24, 2025

Explore healthcare M&A trends in 2024 and how Enventure guides organizations through strategic growth amid challenges. Navigate the headwinds with us!

March 21, 2025

Healthtech VC rebounds in Q4 2024 with major deals and AI focus. Enventure helps innovators scale, optimize, and prepare for exits in a dynamic market.

March 18, 2025

VC-backed exits hit record lows as IPOs decline. Investors shift to alternative liquidity strategies while capital flows selectively into tech and funds.